目的明确门诊行裂隙灯显微镜下结膜囊肿取出术治疗结膜囊肿的疗效和安全性。方法在门诊病历系统收集2018年3月至2020年3月在中山大学中山眼科中心门诊行裂隙灯显微镜下结膜囊肿取出术共56例57眼结膜囊肿患者。手术过程:术前结膜囊清洁,...目的明确门诊行裂隙灯显微镜下结膜囊肿取出术治疗结膜囊肿的疗效和安全性。方法在门诊病历系统收集2018年3月至2020年3月在中山大学中山眼科中心门诊行裂隙灯显微镜下结膜囊肿取出术共56例57眼结膜囊肿患者。手术过程:术前结膜囊清洁,丙美卡因表面麻醉后,由高年资眼科专科护士在裂隙灯下采用负压抽吸囊肿,完整吸出囊膜,术毕涂抗生素眼药膏。术后随访观察眼表疾病指数(OSDI评分)、复发情况、并发症和患者就医体验。结果56例患者行裂隙灯显微镜下结膜囊肿取出术的手术成功率为100%,患者未出现并发症。患者术后28 d OSDI评分较术前降低,差异有统计学意义(P<0.001),患者就医体验良好,随访1个月、6个月、2年,回访无复发。结论门诊行裂隙灯显微镜下结膜囊肿取出术方便快速,创伤小,术后伤口愈合良好,具有安全性、可行性和有效性,效果好,患者就医体验良好。展开更多
Diabetic eye disease refers to a group of eye complications that occur in diabetic patients and include diabetic retinopathy, diabetic macular edema, diabetic cataracts, and diabetic glaucoma. However, the global epid...Diabetic eye disease refers to a group of eye complications that occur in diabetic patients and include diabetic retinopathy, diabetic macular edema, diabetic cataracts, and diabetic glaucoma. However, the global epidemiology of these conditions has not been well characterized. In this study, we collected information on diabetic eye disease-related research grants from seven representative countries––the United States, China, Japan, the United Kingdom, Spain, Germany, and France––by searching for all global diabetic eye disease journal articles in the Web of Science and Pub Med databases, all global registered clinical trials in the Clinical Trials database, and new drugs approved by the United States, China, Japan, and EU agencies from 2012 to 2021. During this time period, diabetic retinopathy accounted for the vast majority(89.53%) of the 2288 government research grants that were funded to investigate diabetic eye disease, followed by diabetic macular edema(9.27%). The United States granted the most research funding for diabetic eye disease out of the seven countries assessed. The research objectives of grants focusing on diabetic retinopathy and diabetic macular edema differed by country. Additionally, the United States was dominant in terms of research output, publishing 17.53% of global papers about diabetic eye disease and receiving 22.58% of total citations. The United States and the United Kingdom led international collaborations in research into diabetic eye disease. Of the 415 clinical trials that we identified, diabetic macular edema was the major disease that was targeted for drug development(58.19%). Approximately half of the trials(49.13%) pertained to angiogenesis. However, few drugs were approved for ophthalmic(40 out of 1830;2.19%) and diabetic eye disease(3 out of 1830;0.02%) applications. Our findings show that basic and translational research related to diabetic eye disease in the past decade has not been highly active, and has yielded few new treatment methods and newly approved drugs.展开更多
文摘目的明确门诊行裂隙灯显微镜下结膜囊肿取出术治疗结膜囊肿的疗效和安全性。方法在门诊病历系统收集2018年3月至2020年3月在中山大学中山眼科中心门诊行裂隙灯显微镜下结膜囊肿取出术共56例57眼结膜囊肿患者。手术过程:术前结膜囊清洁,丙美卡因表面麻醉后,由高年资眼科专科护士在裂隙灯下采用负压抽吸囊肿,完整吸出囊膜,术毕涂抗生素眼药膏。术后随访观察眼表疾病指数(OSDI评分)、复发情况、并发症和患者就医体验。结果56例患者行裂隙灯显微镜下结膜囊肿取出术的手术成功率为100%,患者未出现并发症。患者术后28 d OSDI评分较术前降低,差异有统计学意义(P<0.001),患者就医体验良好,随访1个月、6个月、2年,回访无复发。结论门诊行裂隙灯显微镜下结膜囊肿取出术方便快速,创伤小,术后伤口愈合良好,具有安全性、可行性和有效性,效果好,患者就医体验良好。
基金supported by the National Natural Science Foundation of China,No.82122009 (to JX)Science Research Foundation ofAier Eye Hospital Group,No.AM2001D1 (to JX)the Natural Science Foundation of Hunan Province,No.2020JJ5002 (to SJ)。
文摘Diabetic eye disease refers to a group of eye complications that occur in diabetic patients and include diabetic retinopathy, diabetic macular edema, diabetic cataracts, and diabetic glaucoma. However, the global epidemiology of these conditions has not been well characterized. In this study, we collected information on diabetic eye disease-related research grants from seven representative countries––the United States, China, Japan, the United Kingdom, Spain, Germany, and France––by searching for all global diabetic eye disease journal articles in the Web of Science and Pub Med databases, all global registered clinical trials in the Clinical Trials database, and new drugs approved by the United States, China, Japan, and EU agencies from 2012 to 2021. During this time period, diabetic retinopathy accounted for the vast majority(89.53%) of the 2288 government research grants that were funded to investigate diabetic eye disease, followed by diabetic macular edema(9.27%). The United States granted the most research funding for diabetic eye disease out of the seven countries assessed. The research objectives of grants focusing on diabetic retinopathy and diabetic macular edema differed by country. Additionally, the United States was dominant in terms of research output, publishing 17.53% of global papers about diabetic eye disease and receiving 22.58% of total citations. The United States and the United Kingdom led international collaborations in research into diabetic eye disease. Of the 415 clinical trials that we identified, diabetic macular edema was the major disease that was targeted for drug development(58.19%). Approximately half of the trials(49.13%) pertained to angiogenesis. However, few drugs were approved for ophthalmic(40 out of 1830;2.19%) and diabetic eye disease(3 out of 1830;0.02%) applications. Our findings show that basic and translational research related to diabetic eye disease in the past decade has not been highly active, and has yielded few new treatment methods and newly approved drugs.
